MAPT and Parkinson disease: Intriguingly, αS and Tau have been found to co-localize in the disease hallmark inclusions of individuals with PD and other synucleinopathies24,25 and a synergistic pathological relationship between these two proteins has been experimentally reported26,27, suggesting a potential cross-talk between αS and Tau aggregation in neurodegenerative disorders.